Table 2.
Systematic reviews finding including physical activity intervention in reducing GDM.
| Systematic Review ID | RCTs Number | Participant Included in Intervention and Control Group (N/n) | Association Measurement | I2 (p) | Quality (Amstar 2) | |
|---|---|---|---|---|---|---|
| Oostdam et al., 2011 [59] | 3 | 125/113 | RD −0.05 (−0.20–0.10) | 66 (0.05) | Critically low | |
| Han et al., 2012 [47] | 5 | 437/389 | RR 1.10 (0.66–1.84) | 0 (0.37) | Low | |
| Yin et al., 2014 [46] | 5 | 497/450 | RR 0.91 (0.57–1.44) | 26 (0.25) | Critically low | |
| Russo et al., 2015 [45] | 10 | 569/520 | RR 0.74 (0.57–0.97) | 12 (0.33) | Critically low | |
| Sanabria-Martínez et al., 2015 [44] | 8 | N.A. | RR 0.69 (0.52–0.91) | 0 (0.61) | Critically low | |
| Madhuvrata et al., 2015 * [23] | 3 | 76/76 | OR 0.77 (0.33–1.79) | 0 (0.53) | Moderate | |
| Aune et al., 2016 [19] | 12 | 9804 ** | RR 0.69 (0.50–0.96) | 30.2 (0.15) | Critically low | |
| Song et al., 2016 [20] | 10 | 4161 ** | RR 0.77 (0.54–1.09) | N.A. | Critically low | |
| Da Silva et al., 2017 [43] | 10 | 1883/1907 | RR 0.67 (0.49–0.92) | 33 (0.14) | Critically low | |
| Zheng et al., 2017 [24] | 7 | 550/563 | OR 0.62 (0.43–0.89) | 37 (0.19) | Critically low | |
| Ming et al., 2018 * [42] | 9 | 1472/1509 | RR 0.58 (0.37–0.90) | 46 (0.07) | Low | |
| Davenport et al., 2018 [18] | 27 | 7568/7198 | OR 0.62 (0.52–0.75) | 0 (0.51) | High | |
| Bennett et al., 2018 [22] | 10 | 2981 ** | RR 0.62 (0.50–0.78) | 0 (0.90) | Moderate | |
| Yu et al., 2018 [39] | 6 | 651/719 | RR 0.59 (0.39–0.88) | 46 (0.11) | Critically low | |
| Chatzakis et al., 2019 * [40] | 14 | 575/589 | RR 0.80 (0.60–1.07) | 30 | Low | |
| Du et la., 2019 * [38] | 13 | 550/572 | RR 0.71 (0.57–0.89) | 0 (0.52) | Low | |
| Makaruk et al., 2019 [33] | 10 | 1747/2013 | N.A. | N.A. | Critically low | |
| Nasiri-Amiri et al., 2019 * [37] | 8 | 727/714 | RR 0.76 (0.65–1.08) | 50 (0.05) | Critically low | |
| Guo et al., 2019 [51] | 19 | 5883 ** | RR 0.70 (0.95–0.84) | N.A. | Critically low | |
| Doi et al., 2020 * [36] | 11 | 722/745 | RR 0.69 (0.51–0.94) | 23.2 (0.02) | Low | |
* Population = women at high risk; ** Total sample size; N.A. = Not available; OR = odds ratio; RR = relative risk; RD = risk difference; N = exposed sample size; n = no exposed sample size; and I2(p) = heterogeneity test (p-value).